In this study, we assessed the diagnostic and discriminative capabilities of four biomarkers of sepsis: sMR, PCT, Presepsin, and MCP-1 to distinguish sepsis from severe SIRS in critically ill newly admitted patients with signs of severe acute inflammation on admission. This evidence concerns the gene CCL2 and systemic inflammatory response syndrome.